More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$11.52B
EPS
6.86
P/E ratio
24.8
Price to sales
2.45
Dividend yield
--
Beta
1.73467
Previous close
$165.98
Today's open
$165.46
Day's range
$162.17 - $167
52 week range
$130.23 - $200.44
show more
CEO
Joseph M. Hogan
Employees
20290
Headquarters
Tempe, AZ
Exchange
Nasdaq Global Select
Shares outstanding
70487053
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha • 20 hours ago

Should You Continue to Hold ALGN Stock in Your Portfolio?
Align Technology's Invisalign expansion, strategic alliances and strong stock gains support its prospects, but currency volatility and competition pose risks.
Zacks Investment Research • 21 hours ago

Align Technology to Speak at Upcoming Financial Conference
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following financial conference. The presentation will be webcast live via the Investor Relations section of Align's website at ht.
Business Wire • Nov 10, 2026

Align Technology Announces $270 Million Accelerated Stock Repurchase Agreement
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement (“ASR”) with Goldman Sachs & Co. LLC (“Goldman Sachs”), to repurchase $270 million of Align's common s.
Business Wire • Nov 6, 2026

Align Technology Recognized in Extel's 2026 All-America Executive Team Rankings
TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced recognition in the 2026 All-America Executive Team rankings published by Extel Insights (formerly Institutional Investor Research), which evaluates the qual.
Business Wire • Nov 6, 2026

Align Technology: Q3 Results Expose Weak Pricing Power Amidst Declining Market Share
Align Technology remains the global leader in clear aligners but faces intensifying competition and declining pricing power, especially in North America. ALGN's US market is saturated, with falling shipments, utilization, and revenue per case; international growth is now the primary driver. Gross margins and brand strength are under pressure, with competitors gaining share through lower costs and improved aesthetics.
Seeking Alpha • Nov 2, 2026

Align Technology Opens 2027 Annual Research Program to Advance Orthodontic and Dental Patient Care
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the opening of its 2027 Annual Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to un.
Business Wire • Nov 2, 2026

Align Technology: The Competitive Threat Has Eased, But Growth Remains A Concern
Align Technology faces new catalysts, developments, and litigation progress that shift the investment landscape. Market sentiment currently appears to emphasize the risks associated with ALGN over potential opportunities. I now favor an intrinsic valuation approach based on future cash flows rather than relying solely on multiples or peer averages.
Seeking Alpha • Oct 30, 2026

ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls
Align Technology's Q3 earnings and revenues beat estimates on higher aligner shipments, but a lowered 2026 sales outlook weighs on shares.
Zacks Investment Research • Oct 29, 2026

Align Technology Q3 Earnings Call Highlights
Align Technology NASDAQ: ALGN reported third-quarter 2026 revenue of $1.015 billion, up 1.9% from a year earlier, as higher clear aligner volumes and international growth helped offset continued pressure in discretionary dental spending and capital-equipment purchasing.
MarketBeat • Oct 29, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Align Technology Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.